On behalf of the operating committee, we are pleased to announce that the Global Congress on Rare Diseases and Orphan Drugs will be held during August 19-20, 2020 in Boston, USA. Rare Diseases Congress 2020 provides a premier interdisciplinary platform for researchers to present the latest research findings and describe emerging technologies, and directions in rare diseases and orphan drugs issues. The event attempts to contribute to presenting novel research results in all aspects of Rare Diseases and Orphan Drugs.
Rare Diseases Congress 2020 provides a platform for scientists, professors, specialists, researchers, students and practitioners to present their latest research results, ideas, developments, and applications in all areas of rare diseases and orphan drugs. The conference will bring together leading academic scientists, researchers, Industrial delegates Healthcare Professionals and scholars in the domain of interest from around the world.
The conference aim is to provide a scientific forum
for all international prestige scholars across the globe and enable the
interactive exchange of knowledge.
Many rare diseases/orphan diseases caused by infectious agents rather than genetic or environmental factors.
A rare disease is defined as a condition that affects less than 200,000 people. Most of the rare diseases are genetic
Diagnostic error in medicine is prevalent. For example, a study from an intensive care unit demonstrated nearly 20%
There are approximately 7,000 rare diseases, which from a regulatory outlook are defined as those diseases where there
Rare cancers caused by simple genetic mutations and common cancers tend to be caused by a complex set of genetic
The advancement of Pharma Industries has eased back as of late due to numerous reasons such as patent generic
A clinical preliminary is a therapeutic report led to test the impacts of another or effectively existing medication
A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate
